» Articles » PMID: 12786977

Expression and Functional Role of MGluR3 and MGluR5 in Human Astrocytes and Glioma Cells: Opposite Regulation of Glutamate Transporter Proteins

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2003 Jun 6
PMID 12786977
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the regulation of glutamate transporter protein expression after stimulation with selective metabotropic glutamate receptor (mGluR) agonists in cultured human glial cells. mGluR3 and mGluR5 are expressed in human astrocytes and in human glioma cells in vivo as well as in vitro, as shown by either RT-PCR or western blot analysis. The selective group I agonist (S)-3,5-dihydroxyphenylglycine produced a significant down-regulation of both GLAST and GLT-1 protein expression in astrocytes cultured in the presence of growth factors. This condition mimics the morphology of reactive glial cells in vivo including an increased expression of mGluR5 protein (observed in pathological conditions). In contrast, (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine, a selective agonist of group II metabotropic glutamate receptors, positively modulates the expression of GLAST and GLT-1 proteins. A similar opposite effect of (S)-3,5-dihydroxyphenylglycine and (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine was observed for the expression of EAAT3 protein in U373 glioblastoma cell line. Selective group I and II antagonists prevented these effects. Pharmacological inhibition of mitogen-activated protein kinase and phosphatidylinositol-3-K pathways reduces the induction of GLT-1 observed in response to the group II metabotropic glutamate receptor agonist (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine. Thus, mGluR3 and mGluR5 can critically and differentially modulate the expression of glutamate transporters and may represent interesting pharmacological targets to regulate the extracellular levels of glutamate in pathological conditions.

Citing Articles

Ketogenic diet induces an inflammatory reactive astrocytes phenotype reducing glioma growth.

Rosito M, Maqbool J, Reccagni A, Mangano M, DAndrea T, Rinaldi A Cell Mol Life Sci. 2025; 82(1):73.

PMID: 39921723 PMC: 11807044. DOI: 10.1007/s00018-025-05600-4.


Expression of group II mGluRs in the inferior colliculus, medial geniculate body, and auditory cortex increases with age.

Kristaponyte I, Beebe N, Harish N, Schofield B, Galazyuk A Neuroscience. 2024; 566:227-238.

PMID: 39694319 PMC: 11824881. DOI: 10.1016/j.neuroscience.2024.12.021.


Metabotropic glutamate receptors-guardians and gatekeepers in neonatal hypoxic-ischemic brain injury.

Mielecki D, Bratek-Gerej E, Salinska E Pharmacol Rep. 2024; 76(6):1272-1285.

PMID: 39289333 PMC: 11582255. DOI: 10.1007/s43440-024-00653-x.


Clavulanic acid inhibits methamphetamine locomotor sensitization in mice and normalizes methamphetamine-induced changes in glutaminase mRNA levels in the nucleus accumbens.

Walters T, Wiah S, Shekarabi A, Milton M, Reddy S, Zhao P Physiol Behav. 2024; 284:114646.

PMID: 39053627 PMC: 11347075. DOI: 10.1016/j.physbeh.2024.114646.


A Mouse Model of Sporadic Alzheimer's Disease with Elements of Major Depression.

Bobkova N, Chuvakova L, Kovalev V, Zhdanova D, Chaplygina A, Rezvykh A Mol Neurobiol. 2024; 62(2):1337-1358.

PMID: 38980563 DOI: 10.1007/s12035-024-04346-7.